Literature DB >> 3748325

Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine.

K M Skoog, S T Cain, C B Nemeroff.   

Abstract

The effects of intracisternally (i.c.) administered neurotensin (NT) on locomotor responses to scopolamine and caffeine, two psychomotor stimulants which do not depend on an intact mesolimbic dopamine (DA) system, were compared with the effects of the peptide on locomotion induced by d-amphetamine, which does depend on this DA system. Adult rats were injected intracisternally with 30 micrograms of neurotensin or vehicle. Immediately following these injections, the rats received intraperitoneal injections of either d-amphetamine (1, 2 or 3 mg/kg), scopolamine (0.25, 0.5, 1.0 or 2.0 mg/kg), caffeine (5, 15, 30 or 50 mg/kg) or the appropriate vehicle. After a 10 min recovery period, interruptions of photocells by ambulatory and non-ambulatory behavior were recorded every 30 min for 2 hr. Analyses of variance indicate that d-amphetamine and caffeine significantly elevated locomotor and non-locomotor activity at every dose tested. Scopolamine elevated locomotor activity at every dose and non-locomotor activity at 0.5, 1.0 and 2.0 mg/kg. Statistical analysis revealed that neurotensin significantly suppressed the locomotor response to 2 and 3 mg/kg of d-amphetamine but did not suppress the locomotor responses to any dose of scopolamine or caffeine or the non-locomotor responses to any of the three stimulants tested. Behavioral ratings of stereotyped responses indicated that neurotensin altered none of these responses to any stimulant tested. These findings are consistent with previous behavioral and biochemical data which indicate that neurotensin modulates the activity of the mesolimbic, but not nigroneostriatal, DA system and moreover, demonstrate that neurotensin does not simply induce a non-specific impairment of locomotor activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3748325     DOI: 10.1016/0028-3908(86)90095-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  CART peptide in the nucleus accumbens regulates psychostimulants: Correlations between psychostimulant and CART peptide effects.

Authors:  Martin O Job; Michael J Kuhar
Journal:  Neuroscience       Date:  2017-02-16       Impact factor: 3.590

2.  Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic.

Authors:  Francis M Hughes; Brooke E Shaner; Lisa A May; Lyndsay Zotian; Justin O Brower; R Jeremy Woods; Michael Cash; Dustin Morrow; Fabienne Massa; Jean Mazella; Thomas A Dix
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

3.  The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.

Authors:  Paul D Shilling; David Feifel
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

4.  Treatment of GABA from Fermented Rice Germ Ameliorates Caffeine-Induced Sleep Disturbance in Mice.

Authors:  Darine Froy N Mabunga; Edson Luck T Gonzales; Hee Jin Kim; Se Young Choung
Journal:  Biomol Ther (Seoul)       Date:  2015-05-01       Impact factor: 4.634

Review 5.  To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance.

Authors:  Juliette A Brown; Hillary L Woodworth; Gina M Leinninger
Journal:  Front Syst Neurosci       Date:  2015-02-18

6.  Determination of neurotensin projections to the ventral tegmental area in mice.

Authors:  Hillary L Woodworth; Juliette A Brown; Hannah M Batchelor; Raluca Bugescu; Gina M Leinninger
Journal:  Neuropeptides       Date:  2018-02-15       Impact factor: 3.286

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.